Related Experiment Video
Updated: May 2, 2026

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
Published on: June 13, 2016
MicroRNAs in the bile of patients with biliary strictures after liver transplantation
Tim O Lankisch1, Torsten Voigtländer, Michael P Manns
1Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany; Integrated Research and Treatment Center-Transplantation, Hannover Medical School, Hannover, Germany.
Abstract:
Biliary complications after liver transplantation remain a major cause of morbidity and reduced graft survival. Ischemic-type biliary lesions (ITBLs) are common and difficult to treat. The pathophysiology of ITBLs remains unclear, and diagnostic markers are still missing. The analysis of microRNA (miRNA) profiles is an evolving field in hepatology. Our aim was to identify specific miRNA patterns in the bile of patients with ITBLs after liver transplantation. Liver transplant patients with biliary complications were included in a cross-sectional study. Patients with ITBLs (n = 37), anastomotic strictures (ASs; n = 39), and bile duct stones (BDSs; n = 12) were compared. Patients with ITBLs were categorized by disease severity. The miRNA concentrations in bile were determined with global miRNA profiling and subsequent miRNA-specific polymerase chain reaction-mediated validation. The concentrations of microRNA 517a (miR-517a), miR-892a, and miR-106a* in bile were increased for patients with ITBLs versus patients with ASs or BDSs (P < 0.05). Categorization by ITBL severity showed higher median concentrations in patients with intrahepatic and extrahepatic strictures (P > 0.05). miR-210, miR-337-5p, miR-577, and miR-329 displayed no statistical differences. In conclusion, miR-517a, miR-892a, and miR-106a* are increased in the bile fluid of patients with ITBLs versus patients with ASs or BDSs. An analysis of miRNA profiles may be useful in the diagnosis and management of patients with ITBLs. Future studies are needed to prove the potential prognostic value of these miRNAs.
Insights
Specific microRNAs (miRNAs) in bile, including miR-517a, miR-892a, and miR-106a*, are elevated in liver transplant patients with ischemic-type biliary lesions (ITBLs). This finding may aid in diagnosing ITBLs, a common complication after liver transplantation.
Area of Science:
- Hepatology
- Transplantation immunology
- Molecular diagnostics
Background:
- Biliary complications, particularly ischemic-type biliary lesions (ITBLs), significantly impact morbidity and graft survival after liver transplantation.
- The underlying mechanisms of ITBLs are not fully understood, and effective diagnostic markers are lacking.
- MicroRNA (miRNA) profiling in bile presents a promising avenue for identifying biomarkers in hepatobiliary diseases.
Purpose of the Study:
- To identify specific miRNA patterns in bile that distinguish ITBLs from other biliary complications post-liver transplantation.
- To evaluate the potential of these miRNAs as diagnostic markers for ITBLs.
Main Methods:
- A cross-sectional study involving liver transplant patients with biliary complications: ITBLs (n=37), anastomotic strictures (ASs; n=39), and bile duct stones (BDSs; n=12).
- Global miRNA profiling of bile samples followed by polymerase chain reaction (PCR)-mediated validation for specific miRNAs.
- Analysis of miRNA concentrations based on ITBL severity (intrahepatic and extrahepatic strictures).
Main Results:
- Concentrations of miR-517a, miR-892a, and miR-106a* were significantly increased in the bile of patients with ITBLs compared to those with ASs or BDSs (P < 0.05).
- Higher median concentrations of these miRNAs were observed in patients with intrahepatic and extrahepatic ITBL strictures, though not statistically significant (P > 0.05).
- No significant differences were found for miR-210, miR-337-5p, miR-577, and miR-329 between groups.
Conclusions:
- miR-517a, miR-892a, and miR-106a* are elevated in bile from liver transplant recipients with ITBLs, differentiating them from ASs and BDSs.
- miRNA profiling in bile holds potential for the diagnosis and management of ITBLs.
- Further research is warranted to confirm the prognostic value of these identified miRNAs in ITBLs.

